Welcome in our Alpha hub InnoFluidics!
InnoFluidics aims for decreasing the cancer burden by providing innovative technologies. InnoFluidics’ rare cell analysis platform will purify and collect tumor cells that are circulating in blood with a simple blood test. As these cells contain all the information related to the disease, our proprietary technology will guide specialists in their clinical decision making and be used as a tool for drug development. We have proved the validity of our approach with model samples and now working for building a prototype to be tested in clinics.